Ugandan scientists plan to develop vaccine for crimean-congo hemorrhagic fever
Available studies indicate that about three billion people globally, are at a risk of contracting the zoonotic viral illness, and yet there is no licensed vaccine nor antiviral drug available to curb the looming scourge.
Assistant Prof, Sheia Balinda, the principal investigator of the study. (Photo by Julius Luwemba)
Scientists under the Uganda Virus Research Institute and Medical Research Council (MRC), have embarked on a study to develop a vaccine that will tackle crimean-congo hemorrhagic fever (CCHF)
Login to begin your journey to our premium content
Tags:
Uganda
Health
Scientists
Vaccine
Crimean Congo Hemorrhagic Fever
Uganda Virus Research Institute and Medical Research Council